Clinical trials
Phase 2 trials in Poland with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
51 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2017 | 2 |
| 2018 | 5 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 12 |
| 2022 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 51 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Maria Sklodowska-Curie National Research Institute of Oncology | 6 |
| Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice | 2 |
| Medical University of Lodz | 2 |
| Medical University of Warsaw | 2 |
| Polish Myeloma Consortium | 2 |
| Pomeranian Medical University Szczecin | 2 |
| University of Warmia and Mazury | 2 |
| Applied Molecular Transport | 1 |
| Axcella Health, Inc | 1 |
| Beijing InnoCare Pharma Tech Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liposarcoma, Myxoid | 3 |
| Multiple Myeloma | 3 |
| Sarcoma | 3 |
| Fibrosarcoma | 2 |
| Hepatitis C, Chronic | 2 |
| Histiocytoma, Malignant Fibrous | 2 |
| Leiomyosarcoma | 2 |
| Liposarcoma | 2 |
| Neuroendocrine Tumors | 2 |
| Neurofibrosarcoma | 2 |
Trials
Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.